US · LUCYW
Innovative Eyewear, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- North Miami, FL 33181
- Website
- lucyd.co
Price · as of 2024-12-31
—
Market cap 320.46K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $24.69 | — |
| Intrinsic Value(DCF) | $450,551.95 | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $0.00 | $0.00 | |||
| 2022 | $0.39 | $305.62 | $6,651.71 | $0.00 | $0.00 |
| 2023 | $0.06 | $115.36 | $55,061.61 | $0.00 | $0.00 |
| 2024 | $0.04 | $24.69 | $4,025.69 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Innovative Eyewear, Inc.'s (LUCYW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $24.69
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$450,551.95
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| LUCYW | Innovative Eyewear, Inc. | $0.06 | 320.46K | +41,119% | +752,173,439% | — | — | -0.01 | 0.01 | 0.04 | 0.98 | — | 0.01 | 13.15% | -484.20% | -474.60% | -106.00% | -557.55% | -96.74% | 0.00 | — | 12.52 | 10.38 | 0.35 | -5904.00% | 4199.00% | 1643.00% | -11148.67% | -9.14 | -493.01% | 0.00% | 0.00% | 0.00% | 0.94 | 1.06 | -4.56 | -4.92 |
| ADXN | Addex Therapeutics Ltd | $7.28 | 4.81M | +9,333% | +38% | +845% | — | 0.71 | 0.52 | 12.45 | -0.37 | — | 0.52 | 100.00% | -681.82% | 1746.04% | 130.39% | -137.95% | 92.11% | 0.00 | -776.78 | 4.42 | 4.19 | 0.71 | -15000.00% | -7495.00% | -3281.00% | -106.85% | -6.70 | -269.11% | 0.00% | 0.00% | 0.00% | -0.63 | -0.32 | 4.27 | -43.82 |
| ALZN | Alzamend Neuro, Inc. | $2.01 | 6.31M | — | — | — | — | -0.28 | 0.32 | — | 0.60 | — | 0.32 | 0.00% | — | — | -657.17% | 339.39% | -172.50% | 0.00 | -249.42 | 6.58 | 6.22 | 0.89 | -9145.00% | — | -1840.00% | -539.27% | -10.35 | 518.36% | 0.00% | 0.00% | 304.12% | 0.59 | 0.39 | — | -18.90 |
| BNGO | Bionano Genomics, Inc. | $1.15 | 3.78M | +6,408% | +42% | — | +30,750% | -0.07 | 0.22 | 0.25 | -0.26 | — | 0.30 | 1.23% | -337.87% | -363.98% | -170.33% | -128.38% | -76.97% | 0.77 | -359.80 | 1.06 | 0.38 | -0.19 | -9964.00% | -1479.00% | -4559.00% | -889.15% | -1.85 | -85.22% | 0.00% | 0.00% | 558.30% | -0.25 | -0.37 | 0.83 | -16.59 |
| EVOK | Evoke Pharma, Inc. | $11.00 | 18.95M | +308% | +3,860,968% | — | — | -1.38 | 1.05 | 0.72 | 0.22 | — | 1.05 | 96.52% | -50.77% | -52.22% | -240.09% | 280.01% | -43.54% | 0.73 | -10.38 | 1.66 | 1.54 | 1.74 | -8995.00% | 9784.00% | 950.00% | -73.85% | -0.53 | 293.71% | 0.00% | 0.00% | 117.66% | 0.20 | 0.19 | -0.10 | -9.79 |
| PLRZ | Polyrizon Ltd. | $12.49 | 13.01M | — | — | — | — | -8.81 | 2.58 | — | -7.77 | — | 5.67 | 0.00% | — | — | -57.83% | -88.33% | -50.61% | 0.00 | -434.00 | 10.16 | 9.79 | 1.79 | — | — | 11359.00% | -8.43% | -4.39 | -77.82% | 0.00% | 0.00% | 20.20% | -8.49 | -9.64 | — | 29.76 |
| PMCB | PharmaCyte Biotech, Inc. | $0.69 | 4.69M | — | — | — | — | 0.26 | 0.16 | — | -0.24 | — | 0.16 | 0.00% | — | — | 67.08% | -34.09% | 53.28% | 0.00 | — | 7.68 | 6.60 | -0.49 | -27722.00% | — | 3843.00% | -36.94% | -1.02 | -23.19% | 14.01% | 3.70% | 324.43% | 1.71 | 2.51 | — | -0.52 |
| SNOA | Sonoma Pharmaceuticals, I… | $2.90 | 5.02M | +34,823% | -54% | — | — | -1.19 | 0.93 | 0.29 | 0.27 | — | 0.93 | 38.25% | -25.97% | -24.20% | -65.55% | -250.76% | -24.32% | 0.07 | — | 3.09 | 2.23 | 1.42 | -4756.00% | 1219.00% | -9304.00% | -4.08% | -0.02 | -11.36% | 0.00% | 0.00% | 61.89% | 0.26 | 5.65 | -0.07 | -19.06 |
| VIVS | VivoSim Labs, Inc. | $2.17 | 5.66M | +13,775% | -66% | — | — | -1.08 | 0.26 | 18.70 | 3.47 | — | 0.26 | 96.53% | -8761.11% | -1727.78% | -35.31% | -1138.63% | -23.70% | 0.09 | -1261.60 | 3.25 | 3.04 | 4.69 | -9117.00% | 3211.00% | -3553.00% | -351.80% | -2.53 | -855.05% | 0.00% | 0.00% | 329.11% | 0.61 | 0.81 | -53.31 | -34.45 |
| YDES | YD Bio Limited Ordinary S… | $8.58 | 605.07M | — | — | — | — | — | — | — | — | — | — | 30.44% | -286.45% | -276.58% | -42.69% | -84.41% | -39.29% | 0.00 | -1893.69 | 13.18 | 12.91 | 2.43 | -28010000.00% | 4576.00% | 838627.00% | — | -6.98 | -274.13% | — | 0.00% | — | — | — | — | — |
About Innovative Eyewear, Inc.
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
- CEO
- Harrison Reed Gross
- Employees
- 11
- Beta
- 3.25
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($450,551.95 ÷ —) − 1 = — (DCF, example).